Clinical Trial Update: Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of acid lipase replacement in lysosomal acid lipase deficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lysosomal Acid Lipase Deficiency

Drugs mentioned

• acyl lipase replacement (idk)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Lysosomal Acid Lipase Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2016-04-18